Pro Dex Inc (PDEX) — SEC Filings
Pro Dex Inc (PDEX) — 23 SEC filings. Latest: 8-K (Dec 19, 2025). Includes 13 8-K, 6 10-Q, 2 DEF 14A.
Overview
Pro Dex Inc (PDEX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 19, 2025: On December 18, 2025, PRO DEX INC announced the departure of Director Michael J. O'Leary. The company also elected two new directors, David L. Johnson and Robert J. L. Smith, to its board. These changes are effective immediately.
Sentiment Summary
Across 23 filings, the sentiment breakdown is: 2 bullish, 19 neutral, 2 mixed. The dominant filing sentiment for Pro Dex Inc is neutral.
Filing Type Overview
Pro Dex Inc (PDEX) has filed 13 8-K, 6 10-Q, 2 DEF 14A, 2 10-K with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (23)
Risk Profile
Risk Assessment: Of PDEX's 20 recent filings, 1 were flagged as high-risk, 9 as medium-risk, and 10 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $18.53M |
| Net Income | $4.68M |
| EPS | $1.43 |
| Debt-to-Equity | 0.55 |
| Cash Position | $514K |
| Operating Margin | 16.78% |
| Total Assets | $64.298M |
| Total Debt | $22.785M |
Key Executives
- Michael J. O'Leary
- David L. Johnson
- Robert J. L. Smith
- Mr. Van Kirk
- Mr. Cabillot
- Mr. Swenson
- Rick Van Kirk
- Nicholas J. Swenson
- Raymond E. Cabillot
- Alisha K. Charlton
- Angelita R. Domingo
- William J. Farrell III
- David C. Hovda
- Katrina M.K. Philp
- Michael J. Geringer
Industry Context
PRO-DEX operates in the medical device sector, specifically focusing on surgical instruments. The industry is characterized by innovation, stringent regulatory requirements, and consolidation, as evidenced by the Zimmer Biomet acquisition of Monogram Technologies. Growth is often driven by new product development and strategic acquisitions.
Top Tags
10-Q (5) · board-changes (3) · medical-devices (3) · Medical Devices (2) · material-agreement (2) · financials (2) · financing (2) · corporate-governance (2) · executive-compensation (2) · debt (2)
Executive Compensation
From the most recent DEF 14A filing (Oct 7, 2025):
- Rick Van Kirk — President and Chief Executive Officer
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Sales | $18.53B | Increased 24.43% from $14.892 million in Q3 2024 |
| Net Income | $4.68B | Increased 89.86% from $2.466 million in Q3 2024 |
| Unrealized gain on investments | $3.299B | Significant contributor to net income, up from $433,000 in Q3 2024 |
| Basic net income per share | $1.43 | Increased from $0.76 in Q3 2024 |
| Realized gain | $6.8B | Expected in Q2 fiscal 2026 from Monogram acquisition |
| Potential CVR payments per CVR | $12.37 | Maximum if all Monogram milestones are attained |
| Investments | $10.038B | Increased from $6.740 million at June 30, 2025 |
| Cash and cash equivalents | $514K | Increased from $419,000 at June 30, 2025 |
| Common shares outstanding | 3,262,004 | As of October 29, 2025 |
| Total inventory | $21.564B | Decreased from $22.213 million at June 30, 2025 |
| Fiscal 2025 Sales | $65M | Represents a 24% year-over-year growth and tenth consecutive year of sales growth for Pro-Dex. |
| Year-over-year sales growth | 24% | Indicates the growth rate of Pro-Dex's sales in Fiscal 2025. |
| Annual Meeting Date | 2025-11-20 | Date for the Annual Meeting of Shareholders to vote on key proposals. |
| Shares of Common Stock outstanding | 3,280,004 | Total shares entitled to vote as of the September 23, 2025 record date. |
| Beneficial ownership by Nicholas J. Swenson | 31.2% | Represents a significant stake held by the Chairman of the Board. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Pro Dex Inc (PDEX)?
Pro Dex Inc has 23 recent SEC filings from Jan 2024 to Dec 2025, including 13 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PDEX filings?
Across 23 filings, the sentiment breakdown is: 2 bullish, 19 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Pro Dex Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Pro Dex Inc (PDEX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Pro Dex Inc?
Key financial highlights from Pro Dex Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for PDEX?
The investment thesis for PDEX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Pro Dex Inc?
Key executives identified across Pro Dex Inc's filings include Michael J. O'Leary, David L. Johnson, Robert J. L. Smith, Mr. Van Kirk, Mr. Cabillot and 15 others.
What are the main risk factors for Pro Dex Inc stock?
Of PDEX's 20 assessed filings, 1 were flagged high-risk, 9 medium-risk, and 10 low-risk.
What are recent predictions and forward guidance from Pro Dex Inc?
Forward guidance and predictions for Pro Dex Inc are extracted from SEC filings as they are enriched.